196 related articles for article (PubMed ID: 35293027)
1. A multi-omics-based investigation of the immunological and prognostic impact of necroptosis-related genes in patients with hepatocellular carcinoma.
Yang H; Jiang Q
J Clin Lab Anal; 2022 Apr; 36(4):e24346. PubMed ID: 35293027
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.
Ren H; Zheng J; Cheng Q; Yang X; Fu Q
Front Genet; 2022; 13():900713. PubMed ID: 35957699
[No Abstract] [Full Text] [Related]
3. Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.
Xiang Z; Mranda GM; Zhou X; Xue Y; Wang Y; Wei T; Liu J; Ding Y
Medicine (Baltimore); 2022 Sep; 101(36):e30219. PubMed ID: 36086716
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
Peng YL; Wang LX; Li MY; Liu LP; Li RS
PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
[TBL] [Abstract][Full Text] [Related]
5. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma.
Lu J; Yu C; Bao Q; Zhang X; Wang J
Front Immunol; 2022; 13():973649. PubMed ID: 36081504
[TBL] [Abstract][Full Text] [Related]
7. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients.
Lv W; Yao Q
Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936
[TBL] [Abstract][Full Text] [Related]
8. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
Huo J; Wu L; Zang Y
Life Sci; 2020 Nov; 260():118396. PubMed ID: 32918973
[TBL] [Abstract][Full Text] [Related]
9. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
Liu T; Wu H; Qi J; Qin C; Zhu Q
Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
[TBL] [Abstract][Full Text] [Related]
10. A Risk Model Developed Based on Necroptosis Predicts Overall Survival for Hepatocellular Carcinoma and Identification of Possible Therapeutic Drugs.
Li Z; Fang J; Chen S; Liu H; Zhou J; Huang J; Liu S; Peng Y
Front Immunol; 2022; 13():870264. PubMed ID: 35422802
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
12. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.
Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S
BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
14. Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma.
Qian B; Lin H; Lan T; Li M; Wu X; Lin S; Song Z; Shen S; Peng B
World J Surg Oncol; 2022 Aug; 20(1):252. PubMed ID: 35932027
[TBL] [Abstract][Full Text] [Related]
15. A necroptosis-related gene signature to predict prognosis and immune features in hepatocellular carcinoma.
Zhang K; Li J; Yuan E
BMC Cancer; 2023 Jul; 23(1):660. PubMed ID: 37452311
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
17. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
18. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
20. Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes.
Li YK; Yan LR; Jiang LY; Xu Q; Wang BG
Dis Markers; 2022; 2022():4835826. PubMed ID: 36157211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
